A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients.

NCT00410540 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

202

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain
Analgesics, Opioid

Interventions

DRUG: OROS hydromorphone HCL ; Morphine sulfate

Sponsor

Alza Corporation, DE, USA